Dihydroartemisinin accentuates the anti-tumor effects of photodynamic therapy via inactivation of NF-κB in Eca109 and Ec9706 esophageal cancer cells

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1527-1536

  Li, Yan Jing ^a   Zhou, Jian Hua ^a   Du, Xiao Xue ^a   Jia, De Xin ^a   Wu, Chun Long ^a   Huang, Peng ^a   Han, Yu ^a   Sui, Hong ^a   Wei, Xiao Li ^a   Liu, Lei ^a   Yuan, Heng Heng ^a   Zhang, Ting Ting ^a   Zhang, Wen Jie ^a   Xie, Rui ^a   Lang, Xiao Hui ^a   Liu, Tao ^a   Jiang, Cai Ling ^a   Wang, Li Ying ^a   Bai, Yu Xian ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Dihydroartemisinin; Esophageal cancer; NF B; Photodynamic therapy

Indexed keywords

DIHYDROARTEMISININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; ARTEMISININ DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; ESOPHAGEAL CANCER CELL LINE; ESOPHAGUS CANCER; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; WESTERN BLOTTING; DOWN REGULATION; PROTEIN DNA BINDING; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ESOPHAGEAL NEOPLASMS; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ARTEMISININS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ESOPHAGEAL NEOPLASMS; HUMANS; NF-KAPPA B; PHOTOCHEMOTHERAPY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84901344631     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358716     Document Type: Article

References (28)

1. Xu Y, Yu X, Chen Q, Mao W: Neoadjuvant versus adjuvant treatment: Which one is better for resectable esophageal squamous cell carcinoma World J Surg Oncol 2012;10:173.
2. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, Mark SD, Qiao YL, Taylor PR: Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456-463. (Pubitemid 40038715)
3. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 2003;349:2241-2252. (Pubitemid 37485141)
4. Manoto SL, Houreld NN, Abrahamse H: Phototoxic effect of photodynamic therapy on lung cancer cells grown as a monolayer and three dimensional multicellular spheroids. Lasers Surg Med 2013;45:186-194.
5. Chen X, Zhao P, Chen F, Li L, Luo R: Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer. Lasers Med Sci 2011;26:69-78.
6. Eickhoff A, Jakobs R, Weickert U, Hartmann D, Schilling D, Alsenbesy M, Eickhoff JC, Riemann JF: Long-Segment early squamous cell carcinoma of the proximal esophagus: Curative treatment and long-term follow-up after 5-aminolevulinic acid (5-ALA)-photodynamic therapy. Endoscopy 2006;38:641-643. (Pubitemid 43978538)
7. Granville DJ, Carthy CM, Jiang H, Levy JG, McManus BM, Matroule JY, Piette J, Hunt DW: Nuclear factor-kappaB activation by the photochemo therapeutic agent verteporfin. Blood 2000;95:256-262. (Pubitemid 30017250)
8. Matroule JY, Bonizzi G, Morliere P, Paillous N, Santus R, Bours V, Piette J: Pyropheophorbide-A methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. J Biol Chem 1999;274:2988-3000. (Pubitemid 29075386)
9. Kulikova L, Mikes J, Hyzdalova M, Palumbo G, Fedorocko P: NF-KB is not directly responsible for photoresistance induced by fractionated light delivery in HT-29 colon adenocarcinoma cells. Photochem Photobiol 2010;86:1285-1293.
10. Korbelik M Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB Cancer Lett 2009 281 232-238.
11. Matroule JY, Hellin AC, Morliere P, Fabiano AS, Santus R, Merville MP, PietteJ: Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by Am inopyropheophorbide-photosensitization. Photochem Photobiol 1999;70:540-548. (Pubitemid 129555821)
12. Coupienne I, Bontems S, Dewaele M, Rubio N, Habraken Y , Fulda S, Agostinis P, Piette J: NFkappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-basedphotodynamic therapy. Biochem Pharmacol 2011;81:606-616.
13. Karin M , Cao Y, Greten FR, Li ZW: NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002;2:301-310. (Pubitemid 37328783)
14. Wang SJ, Gao Y, Chen H, Kong R, Jiang HC, Pan SH, Xue DB, Bai XW, Sun B: Dihydroartemisinin inactivates NF-kappaB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett 2010;293:99-108.
15. Lu JJ, Chen SM , Zhang XW, Ding J, Meng LH: The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Invest New Drugs 2011;29:1 276-1283.
16. Ji Y, Zhang YC, Pei LB, Shi LL, Yan JL, Ma XH: Anti-tumor effects of dihydroartemisinin on human osteosarcoma. Mol Cell Biochem 2011;351:99-108.
17. Du XX, Li YJ, W u CL, Zhou JH, Han Y, Sui H, Wei XL, Liu L, Huang P, Yuan HH, Zhang TT, Zhang WJ, Xie R, Lang XH, Jia DX, Bai YX: Initiation of apoptosis, cell cycle arrest and autophagy of esophageal cancer cells by dihydroartemisinin. Biomed Pharmacother 2013;67:417-424.
18. Volanti C, Matroule JY, Piette J: Involvement of oxidative stress in NF-kappaB activation in endothelial cells treated by photodynamic therapy. Photochem Photobiol 2002;75:36-45.
19. Li D, Zhong Y, Zhou Y, Sun H, Zheng X, Zhao C, Yan Y, Lin Y, Liao L, Wang X: Autocrine TNF-a-mediated NF-KB activation is a determinant for evasion of CD40-induced cytotoxicity in cancer cells. Biochem Biophys Res Commun 2 013;436:467-472.
20. Kim HG, Yang JH, Han EH, Choi JH, Khanal T, Jeong MH, Jeong TC, Jeong HG: Inhibitory effect of dihydroartemisinin against phorbolester-induced cyclooxygenase-2 expression in macro phages. Food Chem Toxico 2013;56:93-99.
21. Lee J, Zhang G, Wu X, Xu F, Zhou J, Zhang X: Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-KB modulation. J Cancer Res Clin Oncol 2012;138:2095-2102.
22. Xiao M, Tang Y, Wang YL, Yang L, Li X, Kuang J, Song GL: ART1 Silencing Enhances Apoptosis of Mouse CT26 Cells via the PI3K/Akt/NF-KB Pathway. Cell Physiol Biochem 2013;32:1587-1599.
23. Fahy BN, Schlieman MG, Virudachalam S, Bold RJ: Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: Implicati ons for therapy in pancreatic cancer. J Am Coll Surg 2004;198:591-599. (Pubitemid 38446534)
24. Feril LB Jr, Kondo T, Cui ZG, Tabuchi Y, Zhao QL, Ando H, Misaki T, Yoshikawa H, Umemura S: Apoptosis induced b y the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett 2005;221:145-152. (Pubitemid 40460401)
25. Braicu C, Pileczki V, Irimie A, Berindan-Neagoe I: P53siRNA therapy reduces c ell proliferation, migration and induces apoptosis in triple negative breast cancer cells. Mol Cell Biochem 2013;381:61-68.
26. Barathan M, Mariappan V, Shankar EM, Abdullah BJ, Goh KL, Vadivelu J: Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Cell Death Dis 2013;4:e697.
27. Wang LW, Huang Z , Lin H, Li ZS, Hetzel F, Liu B: Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells. Photodiagnosis Photodyn Ther 2013;10:244-251.
28. Ahn JC, Biswas R, Chung PS: Synergistic effect of radachlorin mediated photodynamic therapy on propolis induced apoptosis in AMC-HN-4 cell lines via caspase dependent pathway. Photodiagnosis Photodyn Ther 2013;10:236-243.